Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer

被引:20
|
作者
Freudenthal, B. [1 ]
Williams, G. R. [1 ]
机构
[1] Imperial Coll London, Mol Endocrinol Lab, Hammersmith Campus,10N5 Commonwealth Bldg, London W12 0NN, England
关键词
Differentiated thyroid cancer; subclinical thyrotoxicosis; TSH suppression; SERUM THYROTROPIN CONCENTRATIONS; ATRIAL-FIBRILLATION; TSH SUPPRESSION; SUBCLINICAL HYPERTHYROIDISM; CARDIOVASCULAR MORTALITY; THERAPY; CARCINOMA; RISK; LEVOTHYROXINE; MANAGEMENT;
D O I
10.1016/j.clon.2016.12.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Differentiated thyroid cancer is the most common form of thyroid cancer and its prognosis is favourable in most cases. Suppression of thyroid stimulating hormone (TSH) by supra-physiological thyroid hormone replacement has been the mainstay of long-term management for over 60 years. However, evidence for a beneficial outcome of TSH suppression is conflicting and intervention must be balanced against adverse effects, particularly affecting the cardiovascular system and skeleton. Here we discuss the role of TSH suppression in the long-term management of differentiated thyroid cancer in the context of risk stratification for disease recurrence and the latest clinical guidelines. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:325 / 328
页数:4
相关论文
共 50 条
  • [1] Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression
    Sohn, Seo Young
    Joung, Ji Young
    Cho, Yoon Young
    Park, Sun Mi
    Jin, Sang Man
    Chung, Jae Hoon
    Kim, Sun Wook
    [J]. ENDOCRINOLOGY AND METABOLISM, 2015, 30 (03) : 343 - 351
  • [2] Long-term follow-up of differentiated thyroid carcinoma in children and adolescents
    Negre Buso, Montserrat
    Garcia Burillo, Amparo
    Simo Perdigo, Marc
    Galofre Mora, Pere
    Boronat de Ferrater, Maria
    Cuberas Borros, Gemma
    Sabado Alvarez, Constantino
    Castell Conesa, Joan
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (11): : 1431 - 1441
  • [3] Long-Term Follow-Up for Differentiated Thyroid Carcinoma Patients: A Reconsideration
    van der Wardt, Robin A. L.
    Persoon, Adrienne C. M.
    Hesselink, Esther N. Klein
    Links, Thera P.
    [J]. THYROID, 2017, 27 (03) : 475 - 476
  • [4] Follow-up of differentiated thyroid cancer
    Furio Pacini
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : S492 - S496
  • [5] Follow-up of differentiated thyroid cancer
    Pacini, F
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (Suppl 2) : S492 - S496
  • [6] The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer - A long-term follow-up study
    Caballero Y.
    López-Tomassetti E.M.
    Favre J.
    Santana J.R.
    Cabrera J.J.
    Hernández J.R.
    [J]. Thyroid Research, 8 (1)
  • [7] Persistently raised thyroid stimulating hormone in adequately treated congenital hypothyroidism on long-term follow-up
    Kara, Cengiz
    Ocal, Gonul
    Berberoglu, Merih
    Siklar, Zeynep
    Adiyaman, Pelin
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2008, 21 (03): : 251 - 256
  • [8] Reply: Long-term Follow-up of Patients with Metastatic Differentiated Thyroid Carcinoma
    Tada Yipintsoi
    Teerapon Premprabha
    Alan Geater
    [J]. World Journal of Surgery, 2010, 34 : 1990 - 1990
  • [9] To the Editor: Long-term Follow-up of Patients with Metastatic Differentiated Thyroid Carcinoma
    Bertagna, Francesco
    Giubbini, Raffaele
    [J]. WORLD JOURNAL OF SURGERY, 2010, 34 (08) : 1988 - 1989
  • [10] To the Editor: Long-term Follow-up of Patients with Metastatic Differentiated Thyroid Carcinoma
    Francesco Bertagna
    Raffaele Giubbini
    [J]. World Journal of Surgery, 2010, 34 : 1988 - 1989